PROGRAM
DAY ONE: Friday 9th May 2014
8:30
Openning Session
11:00
Coffee Break
9:00
Conference#1: Innovative Therapeutic Approaches, Industrial Challenges - Part 1
Chairman: Rémi Urbain, LFB Biotechnologies
Cell Therapy: Industrial Challenges, Sébastien Renouf - LFB CELLforCURE
Industrialization of a stem cell process, how to identify the right strategy? Fabien Moncaubeig - ATMI LIFE SCIENCE - PALL
Antibody Drug Conjugate Design and Development, Véronique Blanc – SANOFI
10:30 Coffee Break
11:00
Conference#1: Innovative Therapeutic Approaches, Industrial Challenges - Part 2
Chairman: Bertrand Garbay, ENSTBB
New Challenges in Gene Therapy: Development of a lentiglobine vector, Olivier Negre - BLUEBIRD BIO
Industrialization of Gene Therapy, Mathias Hebben - GENETHON
Synthetic Biology for Small Molecules of Pharmaceutical Interest: artemisinine and hydrocortisone, Anne-Sophie Coquel - SANOFI
12:30
Lunch Break
14:00
Round Table: A Journey in Biotech Entrepreneurship: Experiences and Feedback.
Chairman: Gary BRANDAM, BIOTEM
Participants:
Gabriel Festoc, President at POLYPLUS-TRANSFECTION SA, Co-Founder at BAOLABS and strategic consultant for biotech companies and investors
Bertrand Coissac, Founder and Managing Director at ASIA BIO CHANNEL, Co-Founder and CEO at BAOLABS
Zaki Sellam, Strategic Business Development & Operations at CARBOMIMETICS & Independant Biotech Consultant
15:00
Conference#2: New Trends in Quality Management & Regulatory Affairs
Chairwoman: Brigitte Lindet, ENSTBB
Virus safety layered strategy in biopharmaceutical processing, Cédric Geyer - MERCK MILLIPORE
Knowledge Management of Quality Systems in Biopharmaceuticals Industries, Yvan Gouttebelle - THE BIOTECH QUALITY GROUP
Paradigm shift in Toxicology: What are the new trends in USA from the FDA's and the US EPA's point of view and the European counterpart, François Busquet, JOHNS HOPKINS UNIVERSITY - CAAT
16:30 Coffee Break
17:00
Conference#3: Company & Technology Presentations
MaSTherCell, Patrick Stragier, Chief Business & Technology Officer
BIOTECH DEVA, Céline Thizon, Project Manager
STALLERGENES, Vincent Lombardi, Head of Immunomonitoring
PALL FORTEBIO, Yasmine Zouicha
18:30
Networking Session
DAY TWO: Saturday 10th May 2014
9:00
Openning Session
9:30
Conference#4: New Trends in Biomanufacturing
Chairman: Xavier Santarelli, ENSTBB
10:30
Coffee Break
Mabs Continuous Production, Steven Strubbe - MERCK BIODEVELOPMENT
An integrated Assessment of High Processing and Administration for a Therapeutic mAb, Nicolas Fouque - NOVIMMUNE
A New Benchmark for Single Use Cell Culture Harvesting, Jerome Pezzini, SARTORIUS STEDIM BIOTECH
11:00
Round Table: Job Opportunity
12:00
Closing Session